The prognostic contribution of estrogen and progesterone receptor status to a modified version of the Nottingham Prognostic Index K. CollettR. SkjærvenB.O. Mæhle OriginalPaper Pages: 1 - 9
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response A. MakrisT.J. PowlesM. Dowsett OriginalPaper Pages: 11 - 20
A prospective study of the significance of gene and chromosome alterations as prognostic indicators of breast cancer patients with lymph node metastases Hitoshi TsudaChinami SakamakiSetsuo Hirohashi OriginalPaper Pages: 21 - 32
Expression of a vitamin D-regulated gene (VDUP-1) in untreated- and MNU-treated rat mammary tissue Xiaoqi YangLindon H. YoungJeffrey M. Voigt OriginalPaper Pages: 33 - 44
Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat S. SinhaJ. KasetaR.J. Santen OriginalPaper Pages: 45 - 51
Multidisciplinary weight management in locoregional breast cancer: results of a phase II study Pamela GoodwinMary Jane EsplenAndrea Miller OriginalPaper Pages: 53 - 64
An assessment of the influence of clinical breast examination reports on the interpretation of mammograms in a breast screening program. Julia A. KnightAlyssa R. LibstugNorman F. Boyd OriginalPaper Pages: 65 - 71
Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice Ilana KoganJames R. BallingerA. Michael Rauth OriginalPaper Pages: 73 - 80
Variation in endometrial thickening in women with amenorrhea on tamoxifen J. ChangT.J. PowlesM. Dowsett OriginalPaper Pages: 81 - 85
Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer Els M.J.J. BernsIris L. van StaverenJohn A. Foekens OriginalPaper Pages: 87 - 92
Effect of menstrual phase on cell proliferative rate of breast cancer Rosella SilvestriniAntonella LuisiMaria Gaetana Di Mauro OriginalPaper Pages: 93 - 94
